Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 53.9 | 0.0 | 0.0 | 3.3 | 26.3 | 25.1 | 57.4 | 16.1 |
Revenue growth | | | -100.0% | -87.3% | 4.5% | -56.2% | 256.2% | -73.2% |
Cost of goods sold | 3.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 1.4 | 1.9 |
Gross profit | 50.4 | 0.0 | 0.0 | 3.3 | 26.3 | 24.8 | 56.0 | 14.2 |
Gross margin | 93.5% | | | 100.0% | 100.0% | 98.6% | 97.6% | 88.0% |
Selling, general and administrative | 84.8 | 56.2 | 17.6 | 19.2 | 22.1 | 31.4 | 45.3 | 54.0 |
Research and development | 36.9 | 39.1 | 25.9 | 24.1 | 36.5 | 32.9 | 65.0 | 76.6 |
EBIT | -79.8 | -95.3 | -47.8 | -39.9 | -32.2 | -39.5 | -49.2 | -116.7 |
EBIT margin | -147.9% | | | -1193.3% | -122.6% | -157.2% | -85.6% | -723.9% |
Pre-tax income | -93.0 | -97.9 | -52.5 | -40.0 | -29.4 | -40.8 | -53.0 | -120.8 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | -0.9 | -1.3 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.4% | 1.8% | 1.1% |
Net income | -93.0 | -97.9 | -52.5 | -40.0 | -29.4 | -45.0 | -52.0 | -122.6 |
Net margin | -172.4% | | | -1196.4% | -111.8% | -179.0% | -90.6% | -760.9% |
|
Diluted EPS | ($0.81) | ($1.09) | ($0.74) | ($0.69) | ($0.52) | ($1.24) | ($1.86) | ($6.51) |
Shares outstanding (diluted) | 114.7 | 90.1 | 71.1 | 58.0 | 56.1 | 36.4 | 27.9 | 18.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|